PAD 0106 (Bromocriptine Mesylate 2.5 mg)
Pill with imprint PAD 0106 is White, Round and has been identified as Bromocriptine Mesylate 2.5 mg. It is supplied by Paddock Laboratories, Inc..
Bromocriptine is used in the treatment of hyperprolactinemia; diabetes, type 2; acromegaly; parkinson's disease and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PAD 0106
Bromocriptine Mesylate
- Imprint
- PAD 0106
- Strength
- 2.5 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents, Prolactin inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Paddock Laboratories, Inc.
- National Drug Code (NDC)
- 00574-0106
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
magnesium stearate,
maleic acid,
povidone k25,
corn starch
Note: Inactive ingredients may vary.
More about bromocriptine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 27 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
- Patient Information
- Bromocriptine (Advanced Reading)
- Bromocriptine (Cycloset)
- Bromocriptine (Parlodel)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.